EOLS

Analyst Sentiment

Wall St. Consensus
Buy
13 analysts·Moderate coverage
71
Score
11 Buy (85%)2 Hold (15%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1185%
Hold
215%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$13.00
+100.0%
Consensus
$15.00
+130.8%
Bull
$17.00
+161.5%
12-Month Target Range13 analysts
$13.00$15.00$17.00
Current $6.50Consensus
Current Price
$6.50
Upside to Consensus
$8.50

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+17.31%
EPS
FY2028
Rev+18.40%
EPS+150.17%
FY2029
Rev+15.06%
EPS+70.88%

Earnings Surprises

Recent Analyst Actions

Feb 4, 2026Mizuho Securities
Evolus price target lowered to $15 from $19 at Mizuho
Target:$15.00
+219.1%from $4.70
Jan 22, 2026BTIG
Evolus price target lowered to $13 from $18 at BTIG
Target:$13.00
+165.3%from $4.90
Jan 13, 2026Stifel Nicolaus
Evolus price target lowered to $17 from $20 at Stifel
Target:$17.00
+194.6%from $5.77
Dec 1, 2025Mizuho Securities
Evolus (EOLS) PT Lowered to $19 at Mizuho
Target:$19.00
+178.6%from $6.82
Oct 3, 2024H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Evolus (EOLS)
Target:$27.00
+58.4%from $17.05
Sep 13, 2024Barclays
Evolus price target raised to $20 from $16 at Barclays
Target:$20.00
+21.5%from $16.46
Sep 13, 2024Mizuho Securities
Evolus (EOLS) PT Raised to $25 at Mizuho
Target:$25.00
+51.9%from $16.46
Jan 29, 2024Barclays
Barclays Upgrades Evolus (EOLS) to Overweight
Target:$16.00
+18.8%from $13.47